Your session is about to expire
← Back to Search
N/A
Smoking and Ventricular Repolarization
N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in qtc 5 minutes before and 5 minutes after cigarette use
Awards & highlights
No Placebo-Only Group
Summary
This trial studies how using electronic and tobacco cigarettes with different nicotine levels affects heart function. Researchers will measure heart activity to see how it impacts the heart's electrical resetting process.
Eligible Conditions
- Long QT Syndrome
- Sudden Cardiac Death
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change in tpe 5 minutes before and 5 minutes after cigarette use
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in tpe 5 minutes before and 5 minutes after cigarette use
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Tpe
Tpe/QT
Tpe/QTc
Secondary study objectives
QT
QTc
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Non-userExperimental Treatment3 Interventions
Non- users will use, in a randomized, crossover fashion with a 4 week washout, an 1) EC with nicotine, 2) EC without nicotine, and 3) an empty EC (control)
Group II: Chronic TC smokerExperimental Treatment3 Interventions
Chronic TC smokers will use, in a randomized, crossover fashion with a 4 week washout, a 1) TC with nicotine (own brand), 2) research TC with very low level nicotine, and 3) a straw (control)
Group III: Chronic EC userExperimental Treatment3 Interventions
Chronic EC users will use, in a randomized, crossover fashion with a 4 week washout, an 1) EC with nicotine, 2) EC without nicotine, and 3) an empty EC (control)
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,567 Previous Clinical Trials
10,266,890 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
26 Previous Clinical Trials
26,285 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a condition that affects your breathing.You are a long-term smoker of electronic cigarettes (e-cigarettes) or other non-tobacco products.
Research Study Groups:
This trial has the following groups:- Group 1: Non-user
- Group 2: Chronic EC user
- Group 3: Chronic TC smoker
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.